Ethyfos 500mg Injection is a supportive cancer care medicine used to protect healthy cells during chemotherapy and radiation therapy. It contains amifostine, a cytoprotective agent that helps reduce damage to normal tissues while cancer treatment is ongoing.

This injection is commonly given to lower the risk of kidney damage caused by cisplatin chemotherapy and to reduce dry mouth (xerostomia) in patients receiving radiation therapy for head and neck cancers. By protecting healthy tissues, Ethyfos helps patients tolerate cancer treatment better.

Product Features

• Effective cytoprotective injectable therapy
• Contains Amifostine 500 mg
• Reduces chemotherapy- and radiotherapy-induced toxicity
• Protects normal cells without reducing anticancer efficacy
• Used with cisplatin-based chemotherapy
• Intravenous injectable formulation
• Manufactured under GMP-compliant standards
• Prescription-required hospital medicine

How It Helps

• Protects healthy cells from chemotherapy- and radiotherapy-induced damage
• Reduces kidney toxicity caused by cisplatin chemotherapy
• Helps prevent dry mouth (xerostomia) in head and neck cancer patients receiving radiotherapy
• Supports safer cancer treatment by improving tolerance to therapy under medical supervision